Clinical trial
Efficacy of Goal Directed Hemodynamic Therapy Based on Noninvasive Monitoring to Reduce Perioperative Complications in Patients With Hip Fracture
NCT02479321 is registered in ClinicalTrials.gov with Juan-Víctor Lorente, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Goal Directed Hemodynamic Therapy Based on Noninvasive Monitoring to Reduce Perioperative Complications in Patients With Hip Fracture
- Lead sponsor
- Juan-Víctor Lorente, MD, PhD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- February 28, 2019
- Enrollment
- 568 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.